Miromatrix Medical Inc.
Miromatrix Medical Inc.（MIRO）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · MIRO · 截至 2023年9月30日
股东结构概览
30
机构持有人数
▼ 1 vs Q2
$8.75M
机构持仓总市值
▼ $2.83M vs Q2
27.42M
总流通股
freeFloat 71.52%
6.70M
13F 申报持股数
▲ 81,639 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
MIRO 最大股东 · 机构持仓
Q3 2023 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
FIRST LIGHT ASSET MANAGEMENT, LLC biological products, (no diagnostic substances) | 2.28M | 8.36% | 8.36% | $2.99B | Nov 14, 2023 | ▲ 52.9K |
GAGNON SECURITIES LLC biological products, (no diagnostic substances) | 1.46M | 5.35% | 5.35% | $1.91B | Nov 14, 2023 | ▲ 16.9K |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 658.5K | 2.42% | 2.42% | $862.70M | Dec 18, 2023 | ▲ 9.3K |
GAGNON ADVISORS, LLC biological products, (no diagnostic substances) | 556.8K | 2.04% | 2.04% | $729.35M | Nov 14, 2023 | — held |
RTW INVESTMENTS, LP biological products, (no diagnostic substances) | 445.2K | 1.63% | 1.63% | $583.24M | Nov 14, 2023 | — held |
MAYO CLINIC biological products, (no diagnostic substances) | 191.6K | 70.32% | 70.32% | $251.03M | Nov 14, 2023 | — held |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 173.8K | 63.77% | 63.77% | $210.34M | Nov 13, 2023 | ▼ 14.0K |
G2 INVESTMENT PARTNERS MANAGEMENT LLC biological products, (no diagnostic substances) | 168.7K | 61.92% | 61.92% | $221.03M | Nov 14, 2023 | ▼ 12.1K |
SWEET FINANCIAL PARTNERS, LLC biological products, (no diagnostic substances) | 139.6K | 51.21% | 51.21% | $182.81M | Oct 23, 2023 | ▲ 2.0K |
PERKINS CAPITAL MANAGEMENT INC biological products, (no diagnostic substances) | 119.3K | 43.79% | 43.79% | $156.00M | Nov 2, 2023 | — held |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2023 对比上季度
Q3 2023
9
增持
+129.2K 股2
新建仓
首次建仓5
减持
−30.3K 股3
清仓
完全退出净股数变化（前50家）
+98.8K
+129.2K / −30.3K
净新增持仓人
+3
新建 2 个 / 退出 3 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
MIRO 内幕交易记录
数据来源：SEC Form 4
0
买入笔数
1
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Heine Lisa Wipperman director | Dec 12, 2023 | U-Tender | 66,943 | $1.75 | $117.2K | 67.4K | Form 4 ↗ |
Heine Lisa Wipperman director | Dec 13, 2023 | D-Return | 67,413 | — | — | 0 | Form 4 ↗ |
Maag Peter director | Dec 12, 2023 | U-Tender | 62,092 | $1.75 | $108.7K | 58.4K | Form 4 ↗ |
Maag Peter director | Dec 13, 2023 | D-Return | 58,368 | — | — | 0 | Form 4 ↗ |
ERB JOHN L director | Dec 12, 2023 | U-Tender | 56,260 | $1.75 | $98.5K | 54.2K | Form 4 ↗ |
ERB JOHN L director | Dec 13, 2023 | D-Return | 54,201 | — | — | 0 | Form 4 ↗ |
ERB JOHN L director | Dec 13, 2023 | D-Return | 25,000 | $3.75 | $93.8K | 0 | Form 4 ↗ |
BUCKMAN PAUL director | Dec 12, 2023 | U-Tender | 52,593 | $1.75 | $92.0K | 54.2K | Form 4 ↗ |
BUCKMAN PAUL director | Dec 13, 2023 | D-Return | 54,201 | — | — | 0 | Form 4 ↗ |
BUCKMAN PAUL director | Dec 13, 2023 | D-Return | 25,000 | $3.75 | $93.8K | 0 | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Miromatrix Medical Inc.（MIRO）主要由机构投资者持有，机构持股比例约为 24.4%。公司内部人员持股约 28.48%，散户及公众持股约占剩余的 47.09%。
Miromatrix Medical Inc. 最大机构股东为 FIRST LIGHT ASSET MANAGEMENT, LLC，截至 September 30, 2023 持有约 2.28 million 股，占总流通股的 8.36%。
目前共有 30 家机构持有 MIRO 股票，合计持仓市值约 $8,749,560，数据来源为最新 SEC 13F 申报。
常见问题
MIRO ownershipMiromatrix Medical Inc.（MIRO）主要由机构投资者持有，机构持股约 24.4%。最大股东为 FIRST LIGHT ASSET MANAGEMENT, LLC，持股比例 8.36%。内部人员持股约 28.48%。数据来源 SEC Form 13F，截至 September 30, 2023。